FR2886154B1 - Composition pour retarder le developpement de la maladie d'alzheimer - Google Patents

Composition pour retarder le developpement de la maladie d'alzheimer

Info

Publication number
FR2886154B1
FR2886154B1 FR0505365A FR0505365A FR2886154B1 FR 2886154 B1 FR2886154 B1 FR 2886154B1 FR 0505365 A FR0505365 A FR 0505365A FR 0505365 A FR0505365 A FR 0505365A FR 2886154 B1 FR2886154 B1 FR 2886154B1
Authority
FR
France
Prior art keywords
alzheimer
delaying
disease
development
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0505365A
Other languages
English (en)
Other versions
FR2886154A1 (fr
Inventor
Dominique Bourgeade
Jean Christophe Anton
Francois Miceli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COTHERA
Original Assignee
COTHERA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COTHERA filed Critical COTHERA
Priority to FR0505365A priority Critical patent/FR2886154B1/fr
Priority to EP06755300A priority patent/EP1890689A2/fr
Priority to US11/921,066 priority patent/US20090181974A1/en
Priority to PCT/EP2006/062608 priority patent/WO2006125810A2/fr
Publication of FR2886154A1 publication Critical patent/FR2886154A1/fr
Application granted granted Critical
Publication of FR2886154B1 publication Critical patent/FR2886154B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
FR0505365A 2005-05-27 2005-05-27 Composition pour retarder le developpement de la maladie d'alzheimer Expired - Fee Related FR2886154B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0505365A FR2886154B1 (fr) 2005-05-27 2005-05-27 Composition pour retarder le developpement de la maladie d'alzheimer
EP06755300A EP1890689A2 (fr) 2005-05-27 2006-05-24 Composition pour retarder le développement de la maladie d'alzheimer
US11/921,066 US20090181974A1 (en) 2005-05-27 2006-05-24 Composition for slowing down the development of alzheimer's disease
PCT/EP2006/062608 WO2006125810A2 (fr) 2005-05-27 2006-05-24 Composition pour retarder le développement de la maladie d'alzheimer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0505365A FR2886154B1 (fr) 2005-05-27 2005-05-27 Composition pour retarder le developpement de la maladie d'alzheimer

Publications (2)

Publication Number Publication Date
FR2886154A1 FR2886154A1 (fr) 2006-12-01
FR2886154B1 true FR2886154B1 (fr) 2010-03-26

Family

ID=35466542

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0505365A Expired - Fee Related FR2886154B1 (fr) 2005-05-27 2005-05-27 Composition pour retarder le developpement de la maladie d'alzheimer

Country Status (4)

Country Link
US (1) US20090181974A1 (fr)
EP (1) EP1890689A2 (fr)
FR (1) FR2886154B1 (fr)
WO (1) WO2006125810A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011143587A1 (fr) * 2010-05-13 2011-11-17 Nitromega Corp. Acides gras nitrés, neuroprotection et/ou inhibition du déclin cognitif
WO2016109853A2 (fr) * 2015-01-02 2016-07-07 Melaleuca, Inc. Compositions de compléments alimentaires
TWI788111B (zh) 2015-01-02 2022-12-21 美商梅拉洛伊卡公司 多元補充品組成物
TWI790189B (zh) 2015-01-02 2023-01-21 美商梅拉洛伊卡公司 細菌組成物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1052637B (de) * 1956-05-03 1959-03-12 Merck Ag E Verfahren zur Herstellung von haltbaren Vitamin-B-Kombinationspraeparaten in Kapselform
SE416374B (sv) * 1974-11-27 1980-12-22 Otc Consult Ab Forfarande for framstellning av fodermedel for fisk
JPS57110176A (en) * 1980-12-27 1982-07-08 Snow Brand Milk Prod Co Ltd Nutrious food composition for tube feeding
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物
FR2544613B1 (fr) * 1983-04-20 1985-10-25 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique, en reanimation et en therapeutique, renfermant une fraction proteique a base de trois types de minipeptides
LU87145A1 (fr) * 1988-02-26 1989-09-20 Oreal Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques
DE69312851T2 (de) * 1992-04-10 1998-01-08 Otsuka Pharma Co Ltd Nahrungsmittelzusammensetzung zur hemmung von der bildung von darmverrottungsprodukten
FR2691616B1 (fr) * 1992-05-27 1995-06-09 Thorel Jean Noel Bio-vecteurs nutritionnels.
FR2706255B1 (fr) * 1993-06-17 1995-10-27 Univ Rennes Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques.
EP0689834A3 (fr) * 1994-07-01 1996-06-05 Willem Jacob Serfontein Additif alimentaire pour l'homme ou les animaux contenant des vitamines et des sels minéraux à libération prolongée
TW360501B (en) * 1996-06-27 1999-06-11 Nestle Sa Dietetically balanced milk product
EP0920813A1 (fr) * 1997-12-08 1999-06-09 Societe Des Produits Nestle S.A. Accélération de la vitesse de digéstion d'une protéine
US6403142B1 (en) * 1998-12-11 2002-06-11 Ralston Purina Company Hypoallergenic pet food
US6569857B1 (en) * 1999-05-03 2003-05-27 Drugtech Corporation Dietary supplement
US20050037065A1 (en) * 1999-05-27 2005-02-17 Drugtech Corporation Nutritional formulations
US6258846B1 (en) * 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
EP1302115A1 (fr) * 2001-10-16 2003-04-16 Societe Des Produits Nestle S.A. Utilisation de cystathionine
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
FR2860976B1 (fr) * 2003-10-20 2006-02-10 Ravi Shrivastava Nouvelles compositions synergiques pour ameliorer la biodisponibilite et l'efficacite des acides gras polyinsatures pour le traitement des troubles du fonctionnement cerebral.

Also Published As

Publication number Publication date
EP1890689A2 (fr) 2008-02-27
WO2006125810A2 (fr) 2006-11-30
FR2886154A1 (fr) 2006-12-01
WO2006125810A3 (fr) 2007-05-10
US20090181974A1 (en) 2009-07-16

Similar Documents

Publication Publication Date Title
EP1809601A4 (fr) Composes destines a la maladie d'alzheimer
EP1940373B8 (fr) 1-fluoro-1-deoxy-scyllo-inositol destine au traitement de la maladie d'alzheimer
IL188165A0 (en) Method for the diagnosis of alzheimer's disease
NO2014009I2 (no) Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser
DK1847524T3 (da) Terphenylderivater til behandling af Alzheimers sygdom
ZA200702382B (en) Processes for the preparation of substituted 2-(2,6-dioxoplperidin-3-yl)-1-oxoisoindolines
EP1928453A4 (fr) Procedes et compositions permettant de prevenir et de traiter les maladies renales
EP1855525A4 (fr) Modeles poisson zebre de la maladie d'alzheimer
FR2882406B1 (fr) Ensemble d'articulation, notamment pour tringlerie de freins de bogies
FR2886154B1 (fr) Composition pour retarder le developpement de la maladie d'alzheimer
EP1954493A4 (fr) Pellicule anticopie à image
FR2891847B1 (fr) Installation pour la preparation d'une composition de couchage
FR2895234B1 (fr) Prothese de disque pour vertebres cervicales
FR2891181B1 (fr) Dispositf pour la fente de buches
GB0414894D0 (en) Biomarkers of alzheimer's disease
FR2882668B1 (fr) Composition pour fonderie
FR2887456B1 (fr) "composition pour le traitement de la dermite estivale"
FR2886594B1 (fr) Volet d'arret sous siege
FR2868312B1 (fr) Patch pour le traitement des levres
FR2885300B1 (fr) Composition topique pour la protection de l'epiderme
FR2921061B1 (fr) Derives d'indolone pour le traitement de la malaria
FR2889420B1 (fr) Vetement moulant pour la pratique de sport aquatique pour femme
FR2891784B1 (fr) Cache pour eclaireur de plaque d'immatriculation
FR2865674B1 (fr) Machine d'affutage de racles pour serigraphie.
FR2895710B1 (fr) Monopode d'arrimage pour brancard

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120131